Communiqués Paradigm Biopharmaceuticals Limited

Actions

Marché Fermé - Australian S.E. 08:10:27 04/09/2026			Varia. 5j.	Varia. 1 janv.
0,2650 ^AUD	+10,42%		+26,19%	-22,06%

28/08	Paradigm Biopharmaceuticals Limited publie ses résultats pour l'exercice clos le 30 juin 2026	CI
13/08	Le protocole de l'essai de phase 3 de Paradigm Biopharmaceuticals sur l'arthrose du genou maintenu après recommandation du comité de surveillance	MT

11/04/23	Australia’s Paradigm Biopharmaceuticals says phase 2 trial in osteoarthritis shows signs of disease modification at 6-month follow-up	AQ
28/07/22	Paradigm Biopharmaceuticals : Quarterly Update and Appendix 4C - quarterly	PU
12/07/22	Paradigm Biopharmaceuticals : Application for quotation of securities - PAR	PU
29/04/22	Paradigm Biopharmaceuticals : Quarterly Update and Appendix 4C - quarterly	PU
24/02/22	Paradigm Biopharmaceuticals : Half Yearly Report and Accounts	PU
01/02/22	Paradigm Biopharmaceuticals : Notification regarding unquoted securities - PAR	PU
31/01/22	Paradigm Biopharmaceuticals : Quarterly Update and Appendix 4C - quarterly	PU
24/01/22	Paradigm Biopharmaceuticals : AGM Presentation	PU
16/12/21	Paradigm Biopharmaceuticals : PAR REPORTS POSTIVE TOPLINE RESULTS IN HEART FAILURE MODEL	PU
24/11/21	Paradigm Biopharmaceuticals : Application for quotation of securities - PAR	PU
08/11/21	Paradigm Presentation to Bell Potter Healthcare Conference	PU
25/11/19	Paradigm Biopharmaceuticals : Cleansing Notice and Appendix 3B	PU